Abstract
Maple syrup urine disease (MSUD) is a hereditary disorder of branched chain amino/keto acid metabolism, caused by a decreased activity of the branched-chain alpha- ketoacid dehydrogenase complex (BCKAD), which leads to abnormal elevated plasma concentrations of branched-chain amino acids (BCAAs) clinically manifested as a heavy burden for Central Nervous system. The toxic accumulation of substrates promotes the development of a severe and rapidly progressive neonatal encephalopathy if treatment is not immediately given. This disorder has a specific medical management in acute phase in order to minimize mortality and morbidity. For all those reasons, it is important to include the MSUD as a possible diagnosis in a encephalopathic newborn. We present a colombian newborn with classical MSUD with fatal outcome as an example of metabolic emergency and a differential diagnosis in the encephalopathic newborn.
| Translated title of the contribution | Genetic and metabolic urgencies in the neonatal intensive care unit: Maple syrup urine disease |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 420-425 |
| Number of pages | 6 |
| Journal | Nutricion Hospitalaria |
| Volume | 32 |
| Issue number | 1 |
| DOIs | |
| State | Published - 01 Jul 2015 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Genetic and metabolic urgencies in the neonatal intensive care unit: Maple syrup urine disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver